St. Johns Investment Management Company LLC Grows Stock Holdings in CVS Health Co. (NYSE:CVS)

St. Johns Investment Management Company LLC increased its position in shares of CVS Health Co. (NYSE:CVS) by 37.8% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 17,799 shares of the pharmacy operator’s stock after buying an additional 4,878 shares during the quarter. St. Johns Investment Management Company LLC’s holdings in CVS Health were worth $1,420,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Atticus Wealth Management LLC raised its position in shares of CVS Health by 149.0% during the 4th quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock valued at $29,000 after buying an additional 219 shares during the period. USA Financial Formulas raised its position in shares of CVS Health by 573.2% during the 4th quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock valued at $30,000 after buying an additional 321 shares during the period. Ables Iannone Moore & Associates Inc. purchased a new stake in shares of CVS Health during the 4th quarter valued at approximately $32,000. Creekmur Asset Management LLC purchased a new stake in shares of CVS Health during the 4th quarter valued at approximately $34,000. Finally, Steph & Co. raised its position in shares of CVS Health by 192.0% during the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock valued at $35,000 after buying an additional 288 shares during the period. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Insider Activity at CVS Health

In related news, Director Edward J. Ludwig purchased 1,000 shares of CVS Health stock in a transaction that occurred on Thursday, May 2nd. The stock was purchased at an average cost of $53.88 per share, with a total value of $53,880.00. Following the completion of the transaction, the director now directly owns 21,630 shares in the company, valued at $1,165,424.40. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.24% of the stock is owned by corporate insiders.

CVS Health Stock Performance

Shares of CVS stock opened at $60.63 on Thursday. The company has a current ratio of 0.81, a quick ratio of 0.61 and a debt-to-equity ratio of 0.78. The firm has a fifty day moving average price of $60.16 and a 200 day moving average price of $70.45. The company has a market cap of $76.11 billion, a P/E ratio of 10.65, a PEG ratio of 0.58 and a beta of 0.53. CVS Health Co. has a 12 month low of $52.77 and a 12 month high of $83.25.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). CVS Health had a net margin of 2.03% and a return on equity of 13.53%. The company had revenue of $88.44 billion during the quarter, compared to analysts’ expectations of $89.33 billion. During the same period last year, the firm earned $2.20 earnings per share. CVS Health’s revenue was up 3.7% on a year-over-year basis. Sell-side analysts predict that CVS Health Co. will post 7.02 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms recently weighed in on CVS. Mizuho dropped their target price on shares of CVS Health from $86.00 to $72.00 and set a “buy” rating for the company in a report on Thursday, May 2nd. Barclays dropped their target price on shares of CVS Health from $78.00 to $63.00 and set an “equal weight” rating for the company in a report on Thursday, May 2nd. UBS Group downgraded shares of CVS Health from a “buy” rating to a “neutral” rating and dropped their target price for the company from $85.00 to $60.00 in a report on Thursday, May 2nd. Piper Sandler lifted their target price on shares of CVS Health from $93.00 to $94.00 and gave the company an “overweight” rating in a report on Friday, March 15th. Finally, Bank of America dropped their target price on shares of CVS Health from $95.00 to $77.00 and set a “buy” rating for the company in a report on Thursday, May 2nd. Eleven investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $75.05.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.